Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

IMMX

Immix Biopharma Inc

Jun 11 • 03:58PM ET

8.10

-0.09 -1.04 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: INCY KYMR NUVL BMRN RYTM VKTX KRYS AXSM MDGL NBIX

| Held by: VTI VXF IWC AVSC TNXT

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.92	Insider Own	24.11%	Shs Outstand	71.19M	Perf Week	-3.86%
Market Cap	576.28M	Forward P/E	-	EPS next Y	-0.65	Insider Trans	0.00%	Shs Float	54.03M	Perf Month	-24.06%
Enterprise Value	486.74M	PEG	-	EPS next Q	-0.18	Inst Own	43.58%	Short Float	7.47%	Perf Quarter	-19.93%
Income	-34.98M	P/S	-	EPS this Y	21.53%	Inst Trans	3.66%	Short Ratio	3.99	Perf Half Y	22.65%
Sales	0.00M	P/B	5.09	EPS next Y	7.28%	ROA	-60.47%	Short Interest	4.03M	Perf YTD	54.78%
Book/sh	1.59	P/C	6.36	EPS next 5Y	39.20%	ROE	-74.47%	52W High	11.61 -30.28%	Perf Year	233.13%
Cash/sh	1.27	P/FCF	-	EPS past 3/5Y	-12.81% -43.32%	ROIC	-41.02%	52W Low	1.94 317.27%	Perf 3Y	306.78%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	7.77% 8.61%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-27.17%	Oper. Margin	-	ATR (14)	0.70	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	8.76	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	39.58	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	8.76	EPS Q/Q	-19.16%	SMA20	-7.07%	Beta	0.17	Target Price	18.50
Payout	-	Debt/Eq	0.01	Sales Q/Q	-	SMA50	-12.35%	Rel Volume	0.95	Prev Close	8.18
Employees	21	LT Debt/Eq	0.01	Earnings	Jun 03	SMA200	32.00%	Avg Volume	1.01M	Price	8.10
IPO	Dec 16, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	0.00% -	Trades		Volume	955,884	Change	-1.04%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)